653 related articles for article (PubMed ID: 19349710)
1. Idiopathic inflammatory myopathies.
Dimachkie MM; Barohn RJ
Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
Dalakas MC
Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
Dalakas MC
Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of inflammatory and autoimmune myopathies.
Dalakas MC
Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory myopathies.
Amato AA; Greenberg SA
Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1615-33. PubMed ID: 24305450
[TBL] [Abstract][Full Text] [Related]
6. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
7. Current Classification and Management of Inflammatory Myopathies.
Schmidt J
J Neuromuscul Dis; 2018; 5(2):109-129. PubMed ID: 29865091
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis of primary inflammatory myopathies].
Benveniste O; Squier W; Boyer O; Hilton-Jones D; Herson S
Presse Med; 2004 Nov; 33(20):1444-50. PubMed ID: 15611679
[TBL] [Abstract][Full Text] [Related]
9. [Idiopathic myositis].
Burgunder JM
Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory muscle diseases.
Mastaglia FL
Neurol India; 2008; 56(3):263-70. PubMed ID: 18974552
[TBL] [Abstract][Full Text] [Related]
11. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
Dalakas MC
J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory myopathies: evaluation and management.
Greenberg SA
Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
[TBL] [Abstract][Full Text] [Related]
13. Polymyositis: an overdiagnosed entity.
van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
[TBL] [Abstract][Full Text] [Related]
14. Update on idiopathic inflammatory myopathies.
Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
[TBL] [Abstract][Full Text] [Related]
15. [Not Available].
Wiendl H
Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S20. PubMed ID: 26536184
[No Abstract] [Full Text] [Related]
16. Inclusion body myositis: clinical and pathological boundaries.
Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic inflammatory myopathies: a review.
Ashton C; Paramalingam S; Stevenson B; Brusch A; Needham M
Intern Med J; 2021 Jun; 51(6):845-852. PubMed ID: 34155760
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic inflammatory myopathies.
van der Kooi AJ; de Visser M
Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315
[TBL] [Abstract][Full Text] [Related]
19. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
20. [Inflammatory myopathies: diagnosis and classifications].
Dimitri D
Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]